Early food introduction in infant diets associated with lower risk of allergic disease
1. Early egg or peanut introduction during the first year of life was associated with lower risk of developing food...
Wearable technology does not improve weight loss when added to behavioral intervention
1. In this randomized controlled trial, wearable fitness technology added to multiple behavioral interventions resulted in significantly less weight loss...
Association between transcatheter aortic valve replacement and subsequent infective endocarditis and death
1. Among all patients undergoing transcatheter aortic valve replacement, an increased risk of infective endocarditis was found in males, younger...
Current therapies ineffective at reducing epistaxis in hereditary hemorrhagic telangiectasia
1. No intranasal drug treatment (bevacizumab, estriol, or tranexamic acid) significantly reduced epistaxis duration compared to placebo. 2. There were...
Bevacizumab nasal spray unable to reduce epistaxis in hereditary hemorrhagic telangiectasia
1. Intranasal bevacizumab failed to reduce mean monthly epistaxis duration in patients with hereditary hemorrhagic telangiectasia in the three consecutive...
Team-based care systems compare favorably with traditional practice models
1. Compared with traditional practice models, patients receiving care as part of a team-based approach utilized care less frequently at...
Abaloparatide protects against vertebral fractures in post-menopausal osteoporotic women
1. Abaloparatide significantly reduced the risk of new vertebral and non-vertebral fractures compared with placebo. 2. Treatment with abaloparatide also...
PCSK9 inhibitors unlikely to be cost-effective
1. For patients with atherosclerotic cardiovascular disease, PCSK9 inhibitors, either in monotherapy for statin-intolerant patients or in addition to statin...
Cerebral protection device effective in patients undergoing transcatheter aortic valve implantation
1. The number and volume of new brain lesions was lower in patients with an implanted cerebral protection device following...
Liraglutide unable to improve post-hospitalization course in patients with advanced heart failure
1. This double-blinded, randomized controlled study found that liraglutide, a GLP-1 agonist, did no better than placebo in influencing post-hospitalization...
